Riccardo Palmisano

Riccardo Palmisano holds a degree in Medicine from the University of Parma. A manager with over 40 years of experience in the pharma and biotech sectors, with strong training in marketing, management, finance, and organization (SDA Bocconi).
Former CEO of MolMed (now AGC Biologics, 2015-2020) and VP/General Manager Italy of Genzyme, with senior/VP roles at GSK, Sanofi, Shire, Menarini, and Farmitalia Carlo Erba. President of Assobiotec (2016-2022), now Past President. Following MolMed acquisition, he served in different roles start-up innovative companies as Betaglue (Executive Chairman) and Innovavector (CEO). Currently Senior Advisor to private equity funds Triton and Quadrivio, Chairman of Biotec Italia (laser equipments for aesthetic medicine), Board member of Navita (immune-oncology), and advisor in the healthcare and life science space, including Diasorin. A profile focused on strategy, business development, and corporate